---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-018802"
form_type: "8-K"
ticker: "LCTX"
cik: "0000876343"
company_name: "Lineage Cell Therapeutics, Inc."
filed_at: "2022-07-07T23:59:59+00:00"
generated_at: "2026-06-24T20:10:05.301934+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CFO Kevin L. Cook resigns; CEO Brian M. Culley named interim CFO effective July 8, 2022

## Summary
- CFO Kevin L. Cook resigns effective July 8, 2022; resignation not due to any disagreement with Lineage.
- CEO Brian M. Culley appointed interim CFO and principal financial officer.
- Alexandra Hernandez, Sr. Director of Finance and Controller, named interim principal accounting officer.
- Separation agreement provides Cook $318,975 lump sum (9 months base salary) and up to 9 months COBRA coverage.

## SEC filing metadata
- accession: 0001493152-22-018802
- form_type: 8-K
- ticker: LCTX
- cik: 0000876343
- company_name: Lineage Cell Therapeutics, Inc.
- filed_at: 2022-07-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/876343/000149315222018802/0001493152-22-018802-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/876343/000149315222018802/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-018802
- JSON: https://secwatch.observer/filing/0001493152-22-018802.json
- Plain text: https://secwatch.observer/filing/0001493152-22-018802.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.